Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone

Advertisement

---

Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone - Participating Faculty

December 8th 2021

Article

---

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

Linda F. Fried, MD, MPH;Natalia Petruski-Ivleva, PhD;Kerstin Folkerts, MSc;Niklas Schmedt, DrPH;Priscilla Velentgas, PhD;Csaba P. Kovesdy, MD

December 8th 2021

Article

---

Medical Costs for Managing Chronic Kidney Disease and Related Complications in Patients With Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD;Jinlin Song, PhD;Elizabeth Faust, MBA, MPH;Karen Yang, BA;Yuxian Du, PhD;Sheldon X. Kong, PhD;Rakesh Singh, PhD

December 8th 2021

Article

---

FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Michał Pochopień, MSc;David Z. I. Cherney, MD, PhD;Kerstin Folkerts, MSc;Pierre Levy, PhD;Aurélie Millier, PhD;Stephen Morris, PhD;Prabir Roy-Chaudhury, MD, PhD;Sean D. Sullivan, PhD;Paul Mernagh, MCom

December 8th 2021

Article

---

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

Linda F. Fried, MD, MPH;Natalia Petruski-Ivleva, PhD;Kerstin Folkerts, MSc;Niklas Schmedt, DrPH;Priscilla Velentgas, PhD;Csaba P. Kovesdy, MD

December 8th 2021

Article

---

eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Michał Pochopień, MSc;David Z. I. Cherney, MD, PhD;Kerstin Folkerts, MSc;Pierre Levy, PhD;Aurélie Millier, PhD;Stephen Morris, PhD;Prabir Roy-Chaudhury, MD, PhD;Sean D. Sullivan, PhD;Paul Mernagh, MCom

December 8th 2021

Article